WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / March 2026 / K260294

510(k) cleared

SF Push-in Anchor

Surgical Fusion Technologies GmbH · Mar 27, 2026 · K260294

FDA cleared the SF Push-in Anchor from Surgical Fusion Technologies GmbH on Mar 27, 2026 under K260294, a traditional 510(k). The device falls under product code MAI, Fastener, Fixation, Biodegradable, Soft Tissue, regulated at 21 CFR 888.3030 as a Class 2 device. The review panel was Orthopedic.

FDA logged the submission as received on Jan 29, 2026. The decision came 57 days later, inside the 90 FDA-day goal for a 510(k).

This is the only decision on file for Surgical Fusion Technologies GmbH in the last 12 months of the tracker.

Questions & Answers

What did FDA clear under K260294?

K260294 is the FDA 510(k) for SF Push-in Anchor, submitted by Surgical Fusion Technologies GmbH. FDA's decision date was Mar 27, 2026, under product code MAI (Fastener, Fixation, Biodegradable, Soft Tissue).

Who makes the SF Push-in Anchor?

Surgical Fusion Technologies GmbH, based in Schlieren, is the applicant of record for K260294.

How long did the K260294 review take?

FDA received the submission on Jan 29, 2026 and issued its decision on Mar 27, 2026, 57 days later.

← All decisions in March 2026